Abstract
Biotechnology Law ReportVol. 32, No. 4 Original ArticlesBiosimilarity and Interchangeability in the Biologics Price Competition and Innovation Act of 2009 and FDA's 2012 Draft Guidance for IndustryBy Hannah KoyfmanBy Hannah KoyfmanSearch for more papers by this authorPublished Online:9 Aug 2013https://doi.org/10.1089/blr.2013.9884AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetailsCited byDoes the United States Need Better Policies Governing Generic Drug Use?Value in Health, Vol. 26, No. 3An Introduction to Biosimilars for the Treatment of Retinal Diseases: A Narrative Review12 March 2022 | Ophthalmology and Therapy, Vol. 11, No. 3Biosimilars in chronic inflammatory diseases: facts and remaining questions 5 years after their introduction in Europe9 August 2021 | Expert Opinion on Biological Therapy, Vol. 22, No. 2A Decade of FDA-Approved Drugs (2010–2019): Trends and Future Directions22 February 2021 | Journal of Medicinal Chemistry, Vol. 64, No. 5BBCIC Research Network Analysis of First-Cycle Prophylactic G-CSF Use in Patients Treated With High–Neutropenia Risk ChemotherapyJournal of the National Comprehensive Cancer Network, Vol. 19, No. 13Barriers and facilitators to conduct high‐quality, large‐scale safety and comparative effectiveness research: The Biologics and Biosimilars Collective Intelligence Consortium experience11 August 2019 | Pharmacoepidemiology and Drug Safety, Vol. 29, No. 7How The ACA Reframed The Prescription Drug Market And Set The Stage For Current Reform EffortsHealth Affairs, Vol. 39, No. 3Biosimilarity tetrahedron2 December 2015 Volume 32Issue 4Aug 2013 InformationCopyright 2013, Mary Ann Liebert, Inc.To cite this article:By Hannah Koyfman.Biosimilarity and Interchangeability in the Biologics Price Competition and Innovation Act of 2009 and FDA's 2012 Draft Guidance for Industry.Biotechnology Law Report.Aug 2013.238-251.http://doi.org/10.1089/blr.2013.9884Published in Volume: 32 Issue 4: August 9, 2013Online Ahead of Print:July 10, 2013PDF download
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
